Literature DB >> 28752238

Exome sequencing reveals a novel homozygous mutation in ACP33 gene in the first Italian family with SPG21.

Marina Scarlato1, Andrea Citterio2, Alessandra Barbieri3, Claudia Godi4, Elena Panzeri2, Maria Teresa Bassi2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28752238     DOI: 10.1007/s00415-017-8558-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  9 in total

1.  Maspardin is mutated in mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia.

Authors:  Michael A Simpson; Harold Cross; Christos Proukakis; Anna Pryde; Ruth Hershberger; Arnaud Chatonnet; Michael A Patton; Andrew H Crosby
Journal:  Am J Hum Genet       Date:  2003-10-16       Impact factor: 11.025

2.  Molecular epidemiology and clinical spectrum of hereditary spastic paraplegia in the Japanese population based on comprehensive mutational analyses.

Authors:  Hiroyuki Ishiura; Yuji Takahashi; Toshihiro Hayashi; Kayoko Saito; Hirokazu Furuya; Mitsunori Watanabe; Miho Murata; Mikiya Suzuki; Akira Sugiura; Setsu Sawai; Kazumoto Shibuya; Naohisa Ueda; Yaeko Ichikawa; Ichiro Kanazawa; Jun Goto; Shoji Tsuji
Journal:  J Hum Genet       Date:  2014-01-23       Impact factor: 3.172

3.  Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia.

Authors:  Marie Coutelier; Cyril Goizet; Alexandra Durr; Florence Habarou; Sara Morais; Alexandre Dionne-Laporte; Feifei Tao; Juliette Konop; Marion Stoll; Perrine Charles; Maxime Jacoupy; Raphaël Matusiak; Isabel Alonso; Chantal Tallaksen; Mathilde Mairey; Marina Kennerson; Marion Gaussen; Rebecca Schule; Maxime Janin; Fanny Morice-Picard; Christelle M Durand; Christel Depienne; Patrick Calvas; Paula Coutinho; Jean-Marie Saudubray; Guy Rouleau; Alexis Brice; Garth Nicholson; Frédéric Darios; José L Loureiro; Stephan Zuchner; Chris Ottolenghi; Fanny Mochel; Giovanni Stevanin
Journal:  Brain       Date:  2015-05-29       Impact factor: 13.501

4.  Cloning of ACP33 as a novel intracellular ligand of CD4.

Authors:  L Zeitlmann; P Sirim; E Kremmer; W Kolanus
Journal:  J Biol Chem       Date:  2000-12-11       Impact factor: 5.157

5.  Hereditary Spastic Paraplegia: Beyond Clinical Phenotypes toward a Unified Pattern of Central Nervous System Damage.

Authors:  Federica Agosta; Marina Scarlato; Edoardo G Spinelli; Elisa Canu; Sara Benedetti; Maria Teresa Bassi; Carlo Casali; Maria Sessa; Massimiliano Copetti; Elisabetta Pagani; Giancarlo Comi; Maurizio Ferrari; Andrea Falini; Massimo Filippi
Journal:  Radiology       Date:  2015-01-22       Impact factor: 11.105

6.  Targeted disruption of the Mast syndrome gene SPG21 in mice impairs hind limb function and alters axon branching in cultured cortical neurons.

Authors:  Cynthia Soderblom; Julia Stadler; Henri Jupille; Craig Blackstone; Oleg Shupliakov; Michael C Hanna
Journal:  Neurogenetics       Date:  2010-07-27       Impact factor: 2.660

7.  Interaction of the SPG21 protein ACP33/maspardin with the aldehyde dehydrogenase ALDH16A1.

Authors:  Michael C Hanna; Craig Blackstone
Journal:  Neurogenetics       Date:  2009-01-31       Impact factor: 2.660

8.  Loss of Maspardin Attenuates the Growth and Maturation of Mouse Cortical Neurons.

Authors:  Anne Davenport; Alexis Bivona; Will Latson; Larry F Lemanski; Venugopalan Cheriyath
Journal:  Neurodegener Dis       Date:  2016-03-16       Impact factor: 2.977

9.  ALDH18A1 gene mutations cause dominant spastic paraplegia SPG9: loss of function effect and plausibility of a dominant negative mechanism.

Authors:  Emanuele Panza; Juan M Escamilla-Honrubia; Clara Marco-Marín; Nadine Gougeard; Giuseppe De Michele; Vincenzo Brescia Morra; Rocco Liguori; Leonardo Salviati; Maria Alice Donati; Roberto Cusano; Tommaso Pippucci; Roberto Ravazzolo; Andrea H Németh; Sarah Smithson; Sally Davies; Jane A Hurst; Domenico Bordo; Vicente Rubio; Marco Seri
Journal:  Brain       Date:  2015-08-21       Impact factor: 13.501

  9 in total
  3 in total

1.  Identification of a large homozygous SPG21 deletion in a Chinese patient with Mast syndrome.

Authors:  Yan-Yan Xue; Xue-Rong Huang; Hai-Lin Dong; Zhi-Ying Wu; Hong-Fu Li
Journal:  CNS Neurosci Ther       Date:  2021-09-07       Impact factor: 5.243

2.  circSPG21 protects against intervertebral disc disease by targeting miR-1197/ATP1B3.

Authors:  Yizhen Huang; Zhenlei Zhang; Jianle Wang; Shuying Shen; Teng Yao; Yining Xu; Zizheng Chen; Bin Fang; Jianjun Ma
Journal:  Exp Mol Med       Date:  2021-10-06       Impact factor: 8.718

3.  Mast Syndrome Outside the Amish Community: SPG21 in Europe.

Authors:  Matthias Amprosi; Elisabetta Indelicato; Wolfgang Nachbauer; Anna Hussl; Claudia Stendel; Andreas Eigentler; Constanze Gallenmüller; Sylvia Boesch; Thomas Klopstock
Journal:  Front Neurol       Date:  2022-01-17       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.